AKT1 and cancer: Most signalling pathways activated by BCR-ABL are involved in promoting the development of cancer in bone marrow cells, including the Ras-MAPK pathway, the Src-Pax-Fak-Rac pathway, the phosphoinositide-3 kinase (PI3K)–Akt pathway, and the JAK-STAT pathway [3–6].